Last checked at 
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
----------
AIM - WINNERS
----------
Sabien Technology Group PLC, up 9.9% at 0.1209 pence, 12-month range 0.05p-0.2p. The energy efficiency technology firm says it has incorporated Sabien Inc, its wholly owned US subsidiary which will operate from San Antonio, Texas. Sabien Inc will be used to source merger and acquisition opportunities for the group in the US and to build and operate distribution channels there for Sabien's current and future European businesses. Danny Mills has been appointed president of the subsidiary. "In my last company and under my leadership, Intercede Group, generated 71% of sales revenues in 2018 from the US. Danny and I are a strong, experienced team, and investors can be confident in our combined abilities to deliver similar levels of performance at Sabien Inc," says Executive Chair Richard Parris.
----------
Tremor International Ltd, up 7.9% at 574p, 12-month range 80p-700p. The video advertising technologies firm reports "record" performance in the second half of 2020 and the fourth quarter. Second half adjusted earnings before interest, tax, depreciation and amortisation is USD58.7 million, up 51% year-on-year. Revenue for 2020 overall is USD211.9 million, down from USD325.8 million in 2019, and Tremor swings to a pretax loss of USD7.4 million from a 2019 profit of USD3.6 million. "Building on the momentum from last year, we have seen a strong start to 2021 compared to the same period, pre Covid-19, in 2020, driven by strong organic growth," company says.
----------
AIM - LOSERS
----------
FastForward Innovations Ltd, down 11% at 9.62p, 12-month range 4.55p-15.5p. The technology and life sciences sector-focused investor says it has conditionally agreed to sell its entire interest in EMMAC Life Sciences Ltd, comprising 6.7 million shares and a GBP750,000 convertible loan note, for GBP5.0 million, ahead of EMMAC being taken over by Curaleaf Holdings Inc. "As an AIM quoted company, FastForward is unable to participate in the Curaleaf transaction due to regulatory conditions surrounding Curaleaf's involvement in the recreational cannabis market in North America. As a result of the sale FastForward will at no time have an interest in Curaleaf's shares," FastForward says. Says main difference to the Curaleaf deal is that Fastforward will not be able to benefit from deferred consideration, though highlights it has been able to liquidate its entire investment in one transaction rather than being restricted under lock ins and variations in the market that it would have otherwise faced had it been party to the Curaleaf transaction.
----------
By Lucy Heming;Â lucyheming@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
